BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28276446)

  • 1. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
    Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
    Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDNF delivery using human neural progenitor cells in a rat model of ALS.
    Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
    Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
    Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
    Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
    Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
    Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
    Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice.
    Guillot S; Azzouz M; Déglon N; Zurn A; Aebischer P
    Neurobiol Dis; 2004 Jun; 16(1):139-49. PubMed ID: 15207271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.
    Trias E; Ibarburu S; Barreto-Núñez R; Babdor J; Maciel TT; Guillo M; Gros L; Dubreuil P; Díaz-Amarilla P; Cassina P; Martínez-Palma L; Moura IC; Beckman JS; Hermine O; Barbeito L
    J Neuroinflammation; 2016 Jul; 13(1):177. PubMed ID: 27400786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
    Foust KD; Flotte TR; Reier PJ; Mandel RJ
    Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.
    Ciriza J; Moreno-Igoa M; Calvo AC; Yague G; Palacio J; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Brûlet P; Osta R
    Restor Neurol Neurosci; 2008; 26(6):459-65. PubMed ID: 19096133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.